Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Based on spectrum to detect ctDNA and its application on the CRC diagnosis and prognosis

ABSTRACT: Interventions: Gold Standard:;Index test: Primary outcome(s): gene mutation Study Design: Diagnostic test for accuracy

DISEASE(S): Colorectal Cancer

PROVIDER: 2661910 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

ctDNA methylation markers in diagnosis and prognosis of hepatocellular carcinoma

Project description:To develop diagnostic and prognostic biomarkers, we compared methylation profiles of HCC tissues and normal blood by analyzing 485,000 CpG markers and identified a HCC enriched methylation marker panel compared to that of normal blood. We found there was a highly correlation of methylation profiles between DNA from HCC cancer tissue and matched plasma ctDNA within the same patient. We then selected 10 markers from this panel and created a combined diagnosis score (cd-score) which showed high diagnostic specificity and sensitivity in both a training cohort and an independent validation cohort. We also showed the cd-score correlate highly with tumor load, treatment response and stage and is superior to that by AFP. We also showed the cd-score correlate highly with tumor load, treatment response and stage and is superior to that by AFP. Additional, we generated 8 markers from unicox and LASSO-cox analysis and created a combined prognosis score (cp-score) which could predict prognosis and survival. Together, these findings demonstrated the utility of ctDNA methylation markers in the diagnosis, treatment evaluation and prognosis of HCC.

2019-01-01 | GSE93203 | GEO

Study of predection for liver metastasis of colorectal carcinoma by serum protein markers spectrum in the tumor area reflux vein

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): distant metastasis Study Design: Diagnostic test for accuracy

| 2662272 | ecrin-mdr-crc

Stool DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer

Project description:Interventions: Gold Standard:colonoscopy;Index test:Stool DNA methylation biomarkers. Primary outcome(s): accuracy Study Design: Diagnostic test for accuracy

| 2680588 | ecrin-mdr-crc

ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC).

Project description:Currently, the standard treatment for patients with localized colorectal cancer (CRC) includes surgical resection followed by adjuvant chemotherapy based on clinicopathological features. Recurrence risk stratification in those patients is of utmost importance to guide clinicians to avoid both under- and overtreatment. Recently, the concept of minimal residual disease (MRD) has emerged as the detection of circulating tumor DNA (ctDNA) carrying tumor-specific genomic or epigenomic alterations in the bloodstream of patients after surgery. Emerging studies described how the detection of MRD is a powerful prognostic biomarker to identify patients at higher risk of recurrence and who will potentially benefit the most from a systemic adjuvant treatment. Based on that unprecedented finding, several clinical trials involving stage II and III CRC patients are ongoing evaluating the impact of ctDNA guided treatment by escalating or deescalating adjuvant chemotherapy based on ctDNA MRD detection. This review provides a critical overview of current perspectives of liquid biopsy in early-stage CRC including technical, biological, and clinical key points, as well as ongoing ctDNA-based clinical trials that ultimately aim to improve clinical outcomes of patients with CRC.

| S-EPMC8226638 | biostudies-literature

Targeted metabolic profiling of tyrosine in urine for colorectal cancer diagnosis

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): the urinary Tyr test Study Design: Diagnostic test for accuracy

| 2662420 | ecrin-mdr-crc

Study on imaging diagnosis of small intestine tumor using magneto - control robot capsule endoscopy

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): Positive rate Study Design: Diagnostic test for accuracy

| 2662018 | ecrin-mdr-crc

MR new technology(3D enhancement+DWI) for assessing diagnosis efficiency about colorectal cancer liver metastases

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): Sensitivity;Accuracy Study Design: Diagnostic test: case-control

| 2662285 | ecrin-mdr-crc

An observational study of ctDNA in evaluating postoperative recurrence and adjuvant treatment efficiency after surgical treatment of colorectal cancer with liver metastasis

Project description:Interventions: Gold Standard:Clinical outcomes;Index test:ctDNA Primary outcome(s): accuracy Study Design: Factorial

| 2699333 | ecrin-mdr-crc

68Ga-NODAGA-R01 PET/CT in the diagnosis of pancreatic cancer, lung cancer, colorectal cancer, gastric cancer, cervical cancer, ovarian cancer, brain glioma

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): SUVmax Study Design: Diagnostic test for accuracy

| 2661966 | ecrin-mdr-crc

The establishment of diagnosis and endoscopic mucosal resection criteria of early colorectal cancer with premalignant lesion in China

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): Invasion depth of colorectal cancer in submucosal layer;Lymph node metastasis Study Design: Diagnostic test for accuracy

| 2662406 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data